exciting randomized trials for mesothelioma: checkpoint inhibitor monotherapies and vinorelbine
Published 6 years ago • 457 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:18
vinorelbine in mesothelioma: the upcoming vim trial
-
0:50
checkpoint inhibition in mesothelioma: the confirm trial
-
1:15
treating mesothelioma with checkpoint inhibitors
-
0:34
managing acute and long-term side effects in checkpoint inhibitors for melanoma
-
0:55
challenges associated with understanding molecular determinants of immune checkpoint blockade
-
1:35
cutting-edge uk trials for mesothelioma: double immuno, arginine depletion and molecular profiling
-
2:02
checkpoint inhibitors in the treatment of thoracic malignancies
-
4:46
mesothelioma causes, symptoms, diagnosis, treatment, pathology
-
3:39
tumor-related immune checkpoints and the development of targeted cancer immunotherapies
-
2:44
how is immunotherapy used to fight cancer? | dana-farber cancer institute | science illustrated
-
4:25
checkpoint inhibitor retreatment after relapse helps few patients
-
2:59
promise-meso: pembrolizumab vs. standard chemotherapy for mesothelioma
-
3:05
therapeutic targets for mesothelioma and sarcomatoid carcinoma
-
2:27
do you order pd-l1 testing before choosing an immune checkpoint inhibitor?
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
5:09
use of checkpoint inhibitors in breast cancer treatment
-
2:07
sostart: start or stop anticoagulants randomised trial
-
2:07
the clearance of driver mutations following allosct impacts myelofibrosis disease outcomes
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
0:47
bo-112: enhancing immune-checkpoint inhibition in solid tumors